Method of treating a disease using a glycolytic dependent compound
US10960021B2 · kind B2 · utility
0Cited by
4References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 11, 2016 |
| Grant date | Mar 30, 2021 |
| Priority date | — |
| Expiry date | Aug 11, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a method of enhancing toxicity of a glycolytic dependent compound towards a cell, tissue and/or organ e.g. a diseased cell, tissue and/or organ, the method comprises contacting Oxidized Regenerated Cellulose (ORC) and/or Oxidized Cellulose (OC); and a glycolytic dependent compound with the cell, tissue and/or organ. The ORC and/or OC; and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.